2008 Top 10 Biopharmaceutical Companies Report

After years of producing this report, I’ve finally settled on definitive criteria for the Top Biopharma ranks! After consulting with Ronald A. Rader, president of the Biotechnology Information Institute, I decided that a Top Biopharma company is one that makes more than 40% of its drug revenues by selling biologic products, including biotherapeutics, vaccines and other proteins. No royalty-based companies allowed! (Sorry, ImClone.)

Unfortunately, this new criteria resulted in my only finding nine qualifying companies. I eventually settled on Elan for the tenth spot, since the company co-markets Tysabri with Biogen Idec. If you can think of other companies that qualify, drop me a line. (But don’t send me any small-molecule companies that call themselves biopharmas! That’s how I got into this mess!)

—Gil Y. Roth, Editor

 

Top 10 Biopharmaceutical Companies
01	Amgen	$14,311
02	Genentech	$9,443
03	Novo Nordisk	$7,696
04	Merck Serono	$6,111
05	Baxter BioScience	$4,649
06	Biogen Idec	$3,063
07	Genzyme*	$2,764
08	CSL Ltd.*	$2,327
09	Allergan*	$1,212
10	Elan*	$446

Based on 2007 biopharma revenues.
Note: In all Top Company profiles, dollar amounts are in millions.

* PDF profiles only available for companies 7-10

 

Contributors

Editor: Gil Y. Roth
Associate Editor: Kristin Brooks
Contributing Editor: Derek B. Lowe

All profiles written by Gil Roth, except Novo Nordisk by Kristin Brooks

The Lowe Down capsules written by Derek Lowe

All pipeline information compiled by Kristin Brooks

Looking for the Top 20 Pharma companies report? Look no further!